New drug offers hope for bowel cancer victims
BOWEL cancer patients in Scotland have been offered new hope with the approval of a drug proven to boost survival rates.
The disease is the second most common cause of cancer death for both men and women, with around 4,000 new patients and 1,600 people dying of the disease in Scotland each year.
Yesterday the Scottish Medicines Consortium (SMC) recommended the use of the drug Erbitux, in combination with chemotherapy treatment, for late-stage bowel cancer patients.
Advertisement
Hide AdAdvertisement
Hide Ad